- Research
- Open access
- Published:
Optimal timing to transfer embryos for women who underwent hysteroscopy: a systematic review and meta-analysis
BMC Pregnancy and Childbirth volume 25, Article number: 453 (2025)
Abstract
Objective
This study aimed to investigate the optimal time interval between hysteroscopy and embryo transfer.
Methods
Electronic databases including PubMed, Embase, and Cochrane Library were searched up to Jul 2021. Two authors selected the articles independently and extracted data regarding study characteristics, quality, and results. A random-effect model was employed, and summary risk ratios (RR) at 95% confidence intervals (CI) were calculated.
Results
A total of 2123 patients from 5 studies were included. Pooled results showed that no significant differences for clinical pregnancy rates within 50-day and 90-day time interval comparison groups (RR = 0.83, 95% CI 0.61–1.11, P = 0.21; and RR = 0.91, 95% CI 0.74–1.12, P = 0.38, respectively), whereas clinical pregnancy rate was significantly increased in patients with a waiting interval of ≤ 120 days (RR = 0.75, 95% CI 0.61–0.93, P = 0.009). Subgroup analysis demonstrated that transferring embryos within 50 days for patients with normal uterine cavities was associated with a higher live birth rate (RR = 0.71, 95% CI 0.54–0.95, P = 0.02).
Conclusion
This meta-analysis identified that performing embryo transfer within 120 days for patients who underwent adhesiolysis and polypectomy within 50 days for patients who underwent diagnostic hysteroscopy was associated with superior outcomes, respectively. These findings may provide evidence to guide clinical decisions for reproductive clinicians. The conclusions might be limited by the small publication numbers. Further studies with a larger sample size were recommended.
Introduction
Embryo transfer is the final and most critical step of in vitro fertilization (IVF) treatment [1, 2]. Successful implantation requires a reciprocal interaction between the blastocysts and endometrium [3, 4]. The functional endometrium provides a suitable microenvironment for the early development of embryos [5, 6]. Thus, assuring the intact and receptivity of endometrium before embryo transfer is a prerequisite for successful implantation [7, 8].
Accumulating evidence indicated that intrauterine pathologies, including endometrial polyps and submucosal myomas, exerted negative influences on fertility via distorting the uterine cavity and impairing endometrial receptivity [9,10,11]. Hysteroscopy is regarded as one of the most efficient approaches for cavity evaluation and correcting intracavity abnormalities [9, 12]. Moreover, emerging evidence proposed that endometrial scratching/injury could enhance endometrial receptivity and decidualization [3, 4, 13]. Therefore, the potential clinical value of hysteroscopy was gradually recognized for women who underwent IVF treatments [9, 14, 15]. However, the optimal timing (immediate transfer vs. transfer after one or more cycles) to perform embryo transfer after hysteroscopy treatment has not reached a consensus [16].
When is the optimal timing to start transferring embryos for women who underwent hysteroscopy has been discussed intensively [16]. Several studies suggested performing hysteroscopy within the IVF-ET (in vitro fertilization and embryo transfer) cycle was beneficial to clinical outcomes [17, 18]. Meanwhile, delaying IVF cycles could not yield superior outcomes, and even bring detrimental effects, especially for women with advanced age [19, 20]. Whereas other researchers hold opposite opinions. For example, previous literature reported that performing hysteroscopy at the oocyte retrieval day or concurrent to the embryo transfer contributed to a decreased implantation rate [21, 22]. This phenomenon might be attributed to the divergent endometrial healing time following different hysteroscopic procedures [16]. Therefore, identifying the optimal waiting period between hysteroscopy and embryo transfer regarding different indications for hysteroscopy, is quite important for fertility outcomes.
Accordingly, in the current study, we performed a systematic review and meta-analysis to evaluate whether the waiting period affected clinical outcomes to determine the optimal timing for embryo transfer following hysteroscopy.
Materials and methods
We performed this review according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement and a protocol (PROSPERO registration number: CRD42021266714).
Search strategy
Electronic databases including Pubmed, Embase, and Cochrane Library were used for searching published studies on the associations between hysteroscopy and embryo transfer up to July 2021. No restrictions on date or type of publication were applied to the search. Regarding the exclusion criteria, non-English studies were not included for the review. The detailed search strategy was displayed in the Supplemental Table 1. The current systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Statement (PRISMA).
Study selection
Titles and abstracts of all identified publications were screened and the full text of the pre-selected articles was reviewed by two researchers (C.L. and Z.L.). If the consensus could not be reached, the disagreements were settled by a discussion with a third author (X.G.).
Studies regarding women who experienced embryo transfer after hysteroscopy treatment were selected for eligibility. Studies were included if they investigated the time interval between hysteroscopy and embryo transfer on pregnancy outcomes. Moreover, studies published in other languages or without clear outcome definitions were excluded, as were literature reviews, case studies, editorials, conference abstracts, and commentaries.
Outcome measurement
The primary outcome was the clinical pregnancy rate. Clinical pregnancy was defined as fetal cardiac activity by sonography. The clinical pregnancy rate was calculated as the number of women with clinical pregnancy divided by the number of women who experienced embryo transfer, per group. The secondary outcomes included live birth rate and miscarriage rate. Live birth rate was calculated as the number of patients who delivered live births divided by the number of patients who had embryo transfer, per group. Miscarriage was defined as women who experienced pregnancy loss after clinical pregnancy, and its rate was calculated as the number of occurrences divided by the number of women with clinical pregnancy, per group.
Data extraction and quality assessment
Both researchers (C.L. and Z.L.) extracted data from the selected articles independently according to a standard protocol. The following information was collected from the eligible studies: author’s name, year of publication, study design, number of patients, number of patients achieved clinical pregnancy, number of patients who gave live birth, number of patients who experienced miscarriages, the time intervals between hysteroscopy and embryo transfer, and the status of transferred embryos.
The Newcastle-Ottawa Scale (NOS) was used to assess the quality of the observational studies included in this review. It is a validated scoring system for evaluating the bias from selection, the comparability, and the outcomes assessment. One or two stars were awarded to each item and studies that met all criteria of NOS would receive a score of up to 9 points. Studies with ≥ 7 points were considered as high-quality. Studies with 5 ~ 7 points were considered as medium quality. Besides, studies with < 5 points were regarded as low quality and excluded from this study. The quality of each included study was independently evaluated by two investigators (C.L. and Y.C.), and discrepancies between the two authors were resolved by two other investigators (L.C. and X.G.).
Assessment of quality of evidence—GRADE pro GDT analysis
For analyzing the overall quality of evidence, GRADE pro GDT (guideline development tool) software was used. The final overall evidence quality as per the GRADE was classified as high, moderate, low, or very low. The GRADE pro GDT software was accessed online from the site: https://gradepro.org/.
Statistical analysis
The time intervals between hysteroscopy and embryo transfer varied among studies. To investigate the optimal timing for embryo transfer, we selected 50 days, 90 days, and 120 days as cut-off points and assassedthe pregnancy outcomes of such points. For meta-analysis on the primary and secondary outcomes, studies were considered comparable if they contained the same time intervals for embryo transfer. For studies where individual patient data or original data were available, outcomes were recalculated according to the time frames discussed in the current review. The summary risk ratios (RR) at 95% confidence intervals (CI) were calculated with a random effect model. Meta-analyses were performed using Review Manager software (version 5.2). To assess the publication bias, a funnel plot analysis using the Egger test was performed. Heterogeneity was assessed using the Q statistic and the I2 statistics. Where I2 was more than 50% or P < 0.05 signifying significant heterogeneity [23]. Results were expressed as forest plots. All P values were two-sided.
Results
Study selection and characteristics
A total of 730 publications were identified by bibliographic researches. Of these, 307 duplicates, 11 published in other languages, 34 abstracts, 117 reviews, and 162 not relevant to the topic were excluded after screening titles (Fig. 1). Next, the remaining publications were screened by abstracts, and 4 reviews/comments, as well as 84 irrelevant articles, were excluded. Then, full-text reading of the remained 11 studies was retrieved for review. Of these, 6 records were conference abstracts. The detailed information of these abstracts and reasons for exclusion were listed in the Supplemental Table 2. Finally, 5 studies were included [20, 24,25,26,27].
Table 1 displays the characteristics and the quality assessment scores of the included studies published from 2012 to 2020. All 5 studies were retrospective in nature and varied in indications for hysteroscopy. All the included study were of high quality (≥ 7 points in NOS). (The detailed scoring of each included studies was displayed in Supplemental Table 3). Additionally, GRADE pro-GDT was used to assess the influence of the waiting period on the clinical pregnancy outcome (Supplemental Table 4). The results indicated that the quality of the evidence is critical for the outcome. In the studies of Karayalçin et al. and Pillai et al., women who presented with normal hysteroscopic findings were enrolled [24, 25], and hysteroscopy was performed for endometrial injury (microtrauma), which might improve the clinical outcomes. In Aharon’s research, the indications for hysteroscopy included polypectomy, myomectomy, lysis of adhesions, septum resection, and retained products of conceptions (POC) [20]. Deng et al. offered hysteroscopy treatment for patients with uterine adhesion [26]. Moreover, in the research of Tu et al., women were indicated with hysteroscopy for polypectomy [27].
The cut-off value of the time interval between hysteroscopy and embryo transfer was different among studies. Two of them regarded 50- and 180-day as cut-off points [24, 25]. One study looked at time intervals in months [20], while another looked at time intervals in seasons [26]. The left study provided raw data for all individual patients and identified a cut-off value of 120-day using the ROC curve [27]. Primary (Fig. 2A) and secondary outcomes (Fig. 2B-C) as reported by the original studies were displayed.
In the study of Aharon et al. [20], the definition of ongoing pregnancy and early pregnancy loss was corresponded to clinical pregnancy and miscarriage of other articles, respectively. Therefore, five studies provided data on clinical pregnancy rate [20, 24,25,26,27], four on live birth rate [24,25,26,27], and three on miscarriage rate [20, 26, 27].
Clinical pregnancy rate
All 5 studies provided data on clinical pregnancy rates. The meta-analysis demonstrated that clinical pregnancy rate was significantly increased in patients with a waiting interval of ≤ 120 days compared to patients with a waiting interval of > 120 days (RR = 0.75, 95% CI 0.61–0.93, P = 0.009; heterogeneity: P = 0.45, I2 = 0%; Fig. 3C). However, no significance was found in the clinical pregnancy rate in the comparison of ≤ 50 days versus > 50 days (RR = 0.83, 95% CI 0.61–1.11, P = 0.21; heterogeneity: P = 0.05, I2 = 67%; Fig. 3A) and < 90 days versus ≥ 90 days (RR = 0.91, 95% CI 0.74–1.12, P = 0.38; heterogeneity: P = 0.19, I2 = 40%; Fig. 3B).
Forest plots presenting the association of time interval between hysteroscopy and embryo transfer with clinical pregnancy rate. (A) Clinical pregnancy rates of patients who underwent embryo transfer ≤ 50 days versus > 50 days following hysteroscopy. (B) Clinical pregnancy rates of patients who underwent embryo transfer < 90 days versus ≥ 90 days following hysteroscopy. (C) Clinical pregnancy rates of patients who underwent embryo transfer ≤ 120 days versus > 120 days following hysteroscopy
Live birth rate
The live birth rate displayed no differences in patients with a waiting interval of > 50 days compared to patients with a waiting interval of ≤ 50 days (RR = 0.82, 95% CI 0.58–1.15, P = 0.25; heterogeneity: P = 0.11, I2 = 56%; Fig. 4A), or ≥ 90 days versus < 90 days (RR = 0.97, 95% CI 0.76–1.22, P = 0.77; heterogeneity: P = 0.74, I2 = 0%; Fig. 4B).
Forest plots presenting the association of time interval between hysteroscopy and embryo transfer with live birth rate. (A) Live birth rates of patients who underwent embryo transfer ≤ 50 days versus > 50 days following hysteroscopy. (B) Live birth rates of patients who underwent embryo transfer < 90 days versus ≥ 90 days following hysteroscopy
Miscarriage rate
Three studies exhibited original data regarding miscarriage. The meta-analysis demonstrated that the miscarriage rate was not different between patients with a time interval of < 90 days compared to patients with a time interval of ≥ 90 days (RR = 0.66, 95% CI 0.35–1.24, P = 0.19; heterogeneity: P = 0.17, I2 = 44%; Fig. 5A), or ≤ 120 days versus > 120 days (RR = 0.62, 95% CI 0.08–4.85, P = 0.65; heterogeneity: P = 0.12, I2 = 59%; Fig. 5B).
Forest plots presenting the association of time interval between hysteroscopy and embryo transfer with miscarriage rate. (A) Miscarriage rates of patients who underwent embryo transfer < 90 days versus ≥ 90 days following hysteroscopy. (B) Miscarriage rates of patients who underwent embryo transfer ≤ 120 days versus > 120 days following hysteroscopy
Subgroup analysis
Subgroup analysis was performed according to the indications for hysteroscopy. Two studies enrolled patients with normal uterine cavities and received hysteroscopy treatment for detecting uterine cavity and endometrial injury (micro-traumas). Two studies performed hysteroscopy for women with polyps and uterine adhesion, respectively, while the other study included multiple conditions, including polyps, myomas, adhesion, septum, and retained POC.
Subgroup analysis for patients with adhesion showed a trend towards an increase in clinical pregnancy rate in the ≤ 120 days group compared to > 120 days group (RR = 0.79, 95% CI 0.62-1.00, P = 0.05; heterogeneity: not applicable, Fig. 6B), however, statistical significance was not reached. Whereas, the miscarriage rate was similar for patients with adhesion were similar between time groups (Fig. 7).
For the polyp subgroup, there was a trend toward a higher clinical pregnancy rate in the time interval of ≤ 120 days compared to > 120 days (RR = 0.65, 95% CI 0.41–1.01, P = 0.06; heterogeneity: not applicable; Fig. 6B). Whereas, the clinical pregnancy rate was similar between the time interval of ≤ 50 days vs. >50 days (RR = 0.85, 95% CI 0.60–1.22, P = 0.39; heterogeneity: not applicable; Fig. 6A). Moreover, no significances of live birth rate (≤ 50 days vs. >50 days, RR = 0.84, 95% CI 0.52–1.36, P = 0.48, heterogeneity: not applicable, Fig. 8A; ≥90 days vs. <90 days, RR = 0.91, 95% CI 0.60–1.38, P = 0.66, heterogeneity: not applicable, Fig. 8B) and miscarriage rate (Fig. 7) were found in time groups.
For endometrial injury subgroup, clinical pregnancy rate was similar between the time groups (≤ 50 days vs. >50 days, RR = 0.84, 95% CI 0.52–1.36, P = 0.48; heterogeneity: P = 0.02, I2 = 81%; Fig. 6A), while the live birth rate significantly favored the time interval ≤ 50 days (RR = 0.71, 95% CI 0.54–0.95, P = 0.02; heterogeneity: P = 0.22, I2 = 32%; Fig. 8A).
For patients with myoma, septum, and retained POC, only data regarding clinical pregnancy were available. Subgroup analysis showed no significance in the clinical pregnancy rate between time groups in women with such pathologies (Suppl Fig. 1). To be specific, for patients with myoma, clinical pregnancy rate was similar between the time groups (< 90 days vs. ≥90 days, RR = 1.29, 95% CI 0.61–2.70, P = 0.51; heterogeneity: not applicable; Suppl Fig. 1). For patients with septum, clinical pregnancy rate was comparable between the time groups (< 90 days vs. ≥90 days, RR = 0.97, 95% CI 0.30–3.18, P = 0.96; heterogeneity: not applicable; Suppl Fig. 1). For women with retained POC, no significance was found regarding clinical pregnancy rate between groups (< 90 days vs. ≥90 days, RR = 2.29, 95% CI 0.37–14.03, P = 0.37; heterogeneity: not applicable; Suppl Fig. 1).
Publication bias
Funnel plots for publications included in different time interval groups were shown in Suppl Fig. 2–4. Results showed no evidence of significant publication bias (Egger test not significant).
Discussion
In the current study, we performed a systematic review and meta-analysis to investigate the optimal time for embryo transfer for women who experienced hysteroscopy. This review was performed in compliance with the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analysis Statement (PRISMA), and a total of 2123 patients from five retrospective cohort studies were included. The time interval between hysteroscopy and embryo transfer varied among studies. Therefore, in the current study, we evaluated the pregnancy outcomes of the recommended time to perform embryo transfer after hysteroscopy: >50 days versus ≤ 50 days (which allowed patients to undergo embryo transfer within that IVF cycle [24]); ≥90 days versus < 90 days (Three months after the hysteroscopy might enable the endometrial healing complete [20]); and > 120 days versus ≤ 120 days. Besides, the optimal time for embryo transfer might be different for women with distinct pathologies. Thus, subgroup analysis was performed. The included publications were of high quality (≥ 7 points), which might improve the reliability of meta-analysis. The heterogeneity was evident in several studies, therefore, the random-effects model (DerSimonian and Laird method) was used for data analysis to reduce its effects [28]. No significant publication bias was found. The pooled results indicated that transferring embryos within 50 days for patients with normal uterine cavity was associated with a higher live birth rate compared to delayed embryo transfer (over 50 days). Moreover, transferring embryos within 120 days posed a higher clinical pregnancy rate for patients with uterine adhesion or endometrial polyps in the current study.
The construction of pregnancy is a highly coordinated process whereby functional embryos attach and invade the maternal endometrium [29]. Thus, uterine endometrium, which provides an appropriate microenvironment for the early development of embryos, is a critical factor for the success of implantation [5, 6]. Uterine pathologies, including polyps, submucous myomas, and adhesion were great threats to embryo implantation and pregnancy. However, even after correcting the intracavitary uterine pathologies via hysteroscopy, the optimal time to perform embryo transfer was still under debate. Therefore, in the present study, we compared the pregnancy outcomes of women who experienced different time intervals between hysteroscopy treatments and embryo transfer. Results indicated no statistically significant differences for the clinical pregnancy rate within the 50-day or 90-day and their comparison groups. Whereas, the clinical pregnancy rate was significantly increased in women who underwent embryo transfer within 120 days after hysteroscopy in this study. This result was not surprising. Prior studies suggested the effect of operative hysteroscopy on endometrial receptivity might display a bimodal pattern [27]. Initially, hysteroscopy treatment disturbed endometrial completion, whereas the sequential inflammation, which induced angiogenesis and promoted cytokines, was beneficial to implantation [30, 31]. Therefore, performing embryo transfer within a shorter time (less than 50 days or 90 days) exhibiting no benefits to clinical pregnancy, was reasonable.
Given the various indications for hysteroscopic treatment, we conducted subgroup analysis to identify the optimal time to transfer embryos for patients with normal uterine cavity, endometrial polyps, or uterine adhesion. In our study, results showed that women with endometrial polyps or uterine adhesion were favored for embryo transfer within 120 days, although no significance was found. This phenomenon was in accordance with our hypothesis, stated above. Moreover, data showed that performing embryo transfer within 50 days was associated with a higher live birth rate for women with normal uterine cavities. Hysteroscopy is considered an excellent approach to evaluate the uterine cavity and correct intrauterine pathologies [32, 33]. Recent evidence suggested that endometrial scratching facilitated endometrial repair, cytokine production, and angiogenesis [22]. Thus, endometrial scratching has been regarded as a potent resort to enhance implantation, especially for women with recurrent implantation failure [34, 35]. Unlike operative hysteroscopy correcting intracavity uterine pathologies, office hysteroscopy performed for women with normal uterine cavity caused microtraumas, which were not visible [24]. Besides, previous literature reported a higher prevalence of endocervical and endometrial damage for women who were difficult for embryo transfer [1, 36]. It had been postulated that hysteroscopy allowed an opportunity to dilate the cervical canal, which, in return, enabled further optimization of embryo transfer procedure [37]. Therefore, commencing embryo transfer soon after office hysteroscopy, which promoted immunological response without disturbing intact endometrium, was favored for the construction of pregnancy.
In this study, our data evaluated the optimal time for embryo transfer after hysteroscopy regarding women with different conditions. The present study, to the best of our knowledge, was the first meta-analysis to address these issues. In this meta-analysis, results showed that a longer waiting period prior to embryo transfer did not favor the clinical pregnancy rates for women who underwent hysteroscopy for different indications, including uterine septum. Generally speaking, hysteroscopic metroplasty would correct the uterine anatomy for women with intrauterine septum [28, 38], however, it also injured the inner face of the myometrium as well as the endometrium, taking quite a time for recovery [16, 39]. According to this point, a longer time following hysteroscopic metroplasty promised uterine recovery and might facilitate reproductive outcomes. Although our results did not support this point, we assumed two possibilities might be responsible for this discrepancy. Firstly, the endometrial layer would not regenerate in the operation zone. A wide area lacking endometrial covering are left on the anterior and posterior uterine walls following surgery [39], decreasing the odds for embryos to implant. On the other hand, the facing wounds were prone to adhere to each other during endometrial rebuilding [16]. Secondary adhesion following metroplasty is another risk for fecundity [39, 40]. In addition, a recent meta-analysis indicated septum resection did not improve the reproductive outcomes for women with a septate uterus [41], which seemed to support our results, stated above.
This meta-analysis explored the optimal timing to transfer embryos for women who underwent hysteroscopy, which was really needed to answer critical questions raised by patients and clinicians. It might provide more evidence for making decisions and provide more chances to attach better clinical outcomes. However, there were several limitations to this review. Firstly, only 5 publications were included for meta-analysis. A lack of studies meant that the number of patients in the subgroup analysis was small. Additionally, several results displayed higher heterogeneity, which might be partly attributed to the limited number of included studies. Subsequent analysis of a greater number of studies could further strengthen these conclusions. Meanwhile, only English language articles were included, thereby, relevant studies published in other languages might be missed. Secondly, there was substantial heterogeneity between two studies evaluating the role of hysteroscopic endometrial injury and its timing prior to IVF outcomes. This was likely derived from discrepancies among the population, or interventions varied among clinicians. However, the high heterogeneity might restrain our conclusion from extrapolating to the general population. Besides, the study design of the included articles was retrospective in nature, which also limited conclusions. Additionally, the time interval of the hysteroscopy and embryo transfer varied among studies. Moreover, the original data, which allowed authors to fully assess the effects of time interval on the pregnancy outcomes, were not available in several studies. Thus, we could not narrow down the optimal time interval precisely. Recent evidence indicated that the transvaginal or transabdominal ultrasound guidance during embryo transfer also affected clinical outcomes [42, 43]. Thus, future discussions on how to perform embryo transfer may improve the current clinical guidelines. Overall, our review suffered from small publication numbers. Further studies with a larger sample size were recommended.
In conclusion, our data showed that performing embryo transfer within 120 days for patients who underwent adhesiolysis or polypectomy could gain a higher clinical pregnancy rate. Besides, transferring embryos within 50 days for patients who underwent diagnostic hysteroscopy was associated with a higher live birth rate in this meta-analysis. These findings might be useful to revise current guidance.
a Data regarding the miscarriage rate was displayed in the supplemental files of the original study. b Miscarriage rate was calculated with the use of original data of all participates that were provided in the supplemental materials of the original study.
Data availability
In this study, all pertinent information is given. However, the corresponding author will provide more information upon reasonable request.
References
Cevrioglu AS, Esinler I, Bozdag G, Yarali H. Assessment of endocervical and endometrial damage inflicted by embryo transfer trial: a hysteroscopic evaluation. Reprod Biomed Online. 2006;13(4):523–7.
Mansour R, Aboulghar M, Serour G. Dummy embryo transfer: a technique that minimizes the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilization. Fertil Steril. 1990;54(4):678–81.
Fatemi HM, Popovic-Todorovic B. Implantation in assisted reproduction: a look at endometrial receptivity. Reprod Biomed Online. 2013;27(5):530–8.
Evans J, Salamonsen LA, Winship A, Menkhorst E, Nie G, Gargett CE, Dimitriadis E. Fertile ground: human endometrial programming and lessons in health and disease. Nat Rev Endocrinol. 2016;12(11):654–67.
Liu C, Yao W, Yao J, Li L, Yang L, Zhang H, Sui C. Endometrial extracellular vesicles from women with recurrent implantation failure attenuate the growth and invasion of embryos. Fertil Steril. 2020;114(2):416–25.
Liu C, Li L, Wang M, Shui S, Yao H, Sui C, Zhang H. Endometrial extracellular vesicles of recurrent implantation failure patients inhibit the proliferation, migration, and invasion of HTR8/SVneo cells. J Assist Reprod Genet. 2021;38(4):825–33.
Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update. 2006;12(6):731–46.
Paul ABM, Sadek ST, Mahesan AM. The role of MicroRNAs in human embryo implantation: a review. J Assist Reprod Genet. 2018.
Bakas P, Hassiakos D, Grigoriadis C, Vlahos N, Liapis A, Gregoriou O. Role of hysteroscopy prior to assisted reproduction techniques. J Minim Invasive Gynecol. 2014;21(2):233–7.
Carbonnel M, Pirtea P, de Ziegler D, Ayoubi JM. Uterine factors in recurrent pregnancy losses. Fertil Steril. 2021;115(3):538–45.
Turocy JM, Rackow BW. Uterine factor in recurrent pregnancy loss. Semin Perinatol. 2019;43(2):74–9.
Mak JN, Imran A, Burnet S. Office hysteroscopy: back to the future! Climacteric. 2020;23(4):350–4.
Ko JK, Ng EH. Scratching and IVF: any role? Curr Opin Obstet Gynecol. 2016;28(3):178–83.
Pundir J, Pundir V, Omanwa K, Khalaf Y, El-Toukhy T. Hysteroscopy prior to the first IVF cycle: a systematic review and meta-analysis. Reprod Biomed Online. 2014;28(2):151–61.
Nahshon C, Sagi-Dain L, Dirnfeld M. The impact of endometrial injury on reproductive outcomes: results of an updated meta-analysis. Reprod Med Biol. 2020;19(4):334–49.
Yang J-H, Chen M-J, Chen C-D, Chen S-U, Ho H-N, Yang Y-S. Optimal waiting period for subsequent fertility treatment after various hysteroscopic surgeries. Fertil Steril. 2013;99(7):2092–6. e2093.
Olesen MS, Hauge B, Ohrt L, Olesen TN, Roskaer J, Baek V, Elbaek HO, Nohr B, Nyegaard M, Overgaard MT, et al. Therapeutic endometrial scratching and implantation after in vitro fertilization: a multicenter randomized controlled trial. Fertil Steril. 2019;112(6):1015–21.
Seval MM, Sukur YE, Ozmen B, Kan O, Sonmezer M, Berker B, Atabekoglu C. Does adding endometrial scratching to diagnostic hysteroscopy improve pregnancy rates in women with recurrent in-vitro fertilization failure? Gynecol Endocrinol. 2016;32(12):957–60.
Pereira N, Amrane S, Estes JL, Lekovich JP, Elias RT, Chung PH, Rosenwaks Z. Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes? Fertil Steril. 2016;105(2):539–e544531.
Aharon D, Sekhon L, Lee JA, Ascher-Walsh C, Copperman AB. Optimal interval of time from operative hysteroscopy to embryo transfer in an in vitro fertilization cycle. J Minim Invasive Gynecol. 2019;26(6):1083–e10871081.
Karimzade MA, Oskouian H, Ahmadi S, Oskouian L. Local injury to the endometrium on the day of oocyte retrieval has a negative impact on implantation in assisted reproductive cycles: a randomized controlled trial. Arch Gynecol Obstet. 2010;281(3):499–503.
Lensen S, Venetis C, Ng EHY, Young SL, Vitagliano A, Macklon NS, Farquhar C. Should we stop offering endometrial scratching prior to in vitro fertilization? Fertil Steril. 2019;111(6):1094–101.
Islam N, Furuya-Kanamori L, Mahmood S, Thalib L. Prophylactic antibiotics for preventing genital tract infection in women undergoing surgical procedures for incomplete abortion: a systematic review and meta-analysis of randomised controlled trials. BJOG. 2021;128(8):1273–81.
Karayalçin R, Ozyer S, Ozcan S, Uzunlar O, Gürlek B, Moraloğlu O, Batioğlu S. Office hysteroscopy improves pregnancy rates following IVF. Reprod Biomed Online. 2012;25(3):261–6.
Pillai A, Parasuram G, Thalakottoor FL, Gopinathan KK. Evaluation of the role of hysteroscopic endometrial injury and its timing prior to in vitro fertilization treatment. Int J Infertility Fetal Med. 2016;7(2):52–7.
Deng K, Song XH, Han XM, Kong WY, Liu W, Han T, Yan L. Optimal waiting period for fresh embryo transfer after hysteroscopic adhesiolysis: a retrospective cohort study. Chin Med J (Engl). 2019;132(19):2333–9.
Tu YA, Yang PK, Chen SU, Yang JH. Optimal time interval between hysteroscopic polypectomy and frozen-thawed blastocyst transfer: A retrospective study. PLoS ONE. 2020;15(10):e0240882.
Garzon S, Lagana AS, Di Spiezio Sardo A, Alonso Pacheco L, Haimovich S, Carugno J, Vitale SG, Casarin J, Raffaelli R, Andrisani A, et al. Hysteroscopic metroplasty for T-Shaped uterus: A systematic review and Meta-analysis of reproductive outcomes. Obstet Gynecol Surv. 2020;75(7):431–44.
Hernandez-Vargas P, Munoz M, Dominguez F. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes. Hum Reprod Update. 2020;26(2):264–301.
Gnainsky Y, Granot I, Aldo PB, Barash A, Or Y, Schechtman E, Mor G, Dekel N. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril. 2010;94(6):2030–6.
Liang Y, Han J, Jia C, Ma Y, Lan Y, Li Y, Wang S. Effect of Endometrial Injury on Secretion of Endometrial Cytokines and IVF Outcomes in Women with Unexplained Subfertility. Mediators Inflamm. 2015; 2015:757184.
What. is the role of office hysteroscopy in women with failed IVF cycles?.
Shiva M, Ahmadi F, Arabipoor A, Oromiehchi M, Chehrazi M. Accuracy of Two-Dimensional transvaginal sonography and office hysteroscopy for detection of uterine abnormalities in patients with repeated implantation failures or recurrent pregnancy loss. Int J Fertil Steril. 2018;11(4):287–92.
Cenksoy P, Ficicioglu C, Yildirim G, Yesiladali M. Hysteroscopic findings in women with recurrent IVF failures and the effect of correction of hysteroscopic findings on subsequent pregnancy rates. Arch Gynecol Obstet. 2013;287(2):357–60.
Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, Cutting R, Ong K, Sallam H, Li TC. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014;28(1):14–38.
Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod. 2006;21(12):3036–43.
Pabuccu R, Ceyhan ST, Onalan G, Goktolga U, Ercan CM, Selam B. Successful treatment of cervical stenosis with hysteroscopic canalization before embryo transfer in patients undergoing IVF: a case series. J Minim Invasive Gynecol. 2005;12(5):436–8.
Esteban Manchado B, Lopez-Yarto M, Fernandez-Parra J, Rodriguez-Oliver A, Gonzalez-Paredes A, Lagana AS, Garzon S, Haimovich S. Office hysteroscopic metroplasty with diode laser for septate uterus: a multicenter cohort study. Minim Invasive Ther Allied Technol. 2020:1–7.
Candiani GB, Vercellini P, Fedele L, Carinelli SG, Merlo D, Arcaini L. Repair of the uterine cavity after hysteroscopic septal incision. Fertil Steril. 1990;54(6):991–4.
Sik BA, Ozdamar O, Ozolcay O, Sismanoglu A, Aba YA, Oral S, Koc M. Second look hysteroscopy following hysteroscopic septum resection improves reproductive outcomes in patients undergoing ICSI. J Obstet Gynaecol. 2022;42(6):2265–71.
Liu C, Liao Z, Gong X, Chen Y. Does septum resection improve reproductive outcomes for women with a septate uterus? A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024;15:1361358.
Cozzolino M, Vitagliano A, Di Giovanni MV, Lagana AS, Vitale SG, Blaganje M, Drusany Staric K, Borut K, Patrelli TS, Noventa M. Ultrasound-guided embryo transfer: summary of the evidence and new perspectives. A systematic review and meta-analysis. Reprod Biomed Online. 2018;36(5):524–42.
Larue L, Keromnes G, Massari A, Roche C, Moulin J, Gronier H, Bouret D, Cassuto NG, Ayel JP. Transvaginal ultrasound-guided embryo transfer in IVF. J Gynecol Obstet Hum Reprod. 2017;46(5):411–6.
Acknowledgements
None.
Funding
The current study was funded by the National Natural Science Foundation of China (NSFC 82201811 and NSFC 82201758) and Jiangsu Natural Science Foundation (No. BK20220173).
Author information
Authors and Affiliations
Contributions
C.L. designed the study. C.L., Z.L., and X.G. contributed to the article selection, data acquisition, and analysis. C.L., Y.L., Y.H. and Y.C. prepared the manuscript, which was edited by Y.C., L.C., and C.L.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
12884_2025_7511_MOESM1_ESM.tif
Supplemental Figure 1. Subgroup meta-analysis by indications for hysteroscopy of clinical pregnancy rate for patients who underwent embryo transfer <90 days versus ≥90 days following hysteroscopy
12884_2025_7511_MOESM2_ESM.tif
Supplemental Figure 2. Funnel plots for publication bias evaluation for the clinical pregnancy rate for women who underwent embryo transfer ≤50 days versus >50 days following hysteroscopy
12884_2025_7511_MOESM3_ESM.tif
Supplemental Figure 3. Funnel plots for publication bias evaluation for the clinical pregnancy rate for women who underwent embryo transfer <90 days versus ≥90 days following hysteroscopy
12884_2025_7511_MOESM4_ESM.tif
Supplemental Figure 4. Funnel plots for publication bias evaluation for the clinical pregnancy rate for women who underwent embryo transfer ≤120 days versus >120 days following hysteroscopy
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Liu, C., Liao, Z., Cai, L. et al. Optimal timing to transfer embryos for women who underwent hysteroscopy: a systematic review and meta-analysis. BMC Pregnancy Childbirth 25, 453 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12884-025-07511-5
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12884-025-07511-5